More about

Eye Drop

News
November 08, 2022
1 min read
Save

Ocuphire enters global license agreement with Famy for Nyxol development

Ocuphire enters global license agreement with Famy for Nyxol development

Ocuphire Pharma and FamyGen Life Sciences have entered into a global licensing agreement that will allow Famy to fund and commercialize the development of Nyxol eye drops in the U.S. as well as globally, according to a press release.

News
August 30, 2022
2 min read
Save

BLOG: How to get started with presbyopia-correcting drops

BLOG: How to get started with presbyopia-correcting drops

With a new pharmaceutical treatment option, my conversations with presbyopic patients have gotten a lot more exciting.

News
August 03, 2022
1 min read
Save

Dosing begins in phase 2 clinical trial of diabetic retinopathy eye drop treatment

The first patient has been dosed in the phase 2 DR:EAM clinical trial assessing OTT166 for the treatment of diabetic retinopathy, according to a press release from OcuTerra Therapeutics.

News
July 01, 2022
2 min watch
Save

VIDEO: iVizia available in US

VIDEO: iVizia available in US

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Marguerite B. McDonald, MD, discusses iVizia, a new dry eye product from Théa Pharma that recently launched in the U.S.

News
July 01, 2022
10 min read
Save

Presbyopia-correcting drops broaden options for younger patients

Presbyopia-correcting drops broaden options for younger patients

Presbyopia is a ubiquitous and progressive symptom of aging that was previously only treatable with reading glasses, contacts or surgery, but patients now have a new option to help their aging eyes: eye drops.

News
July 01, 2022
4 min read
Save

Education, realistic expectations needed for presbyopia-correcting drops

Education, realistic expectations needed for presbyopia-correcting drops

Vuity is our first FDA-approved pharmaceutical agent labeled for the treatment of a refractive error, presbyopia.

News
July 01, 2022
2 min read
Save

Are drops or premium IOLs the long-term solution for presbyopia?

Are drops or premium IOLs the long-term solution for presbyopia?

The future for presbyopia is bright no matter what side you are on. For drops, the benefits are that they are nonsurgical and well tolerated, and the risk profile is relatively safe. The con is that for many patients, they will not work.

News
June 22, 2022
21 min listen
Save

Nanodropper: The Potential Gamechanger with Allisa Song

Nanodropper: The Potential Gamechanger with Allisa Song

In this episode, Allisa Song, a medical student and the CEO and co-founder of Nanodropper, discusses the inception of the device, how it can benefit the eye care industry and more.

News
May 19, 2022
1 min read
Save

Nyxol meets endpoint in phase 3 night vision disturbance trial

Nyxol demonstrated positive topline results in subjects with night vision disturbances in the phase 3 LYNX-1 pivotal clinical trial, Ocuphire Pharma announced in a press release.

News
May 06, 2022
1 min read
Save

BLOG: Three technologies that will change the future of eye drops

BLOG: Three technologies that will change the future of eye drops

Putting an eye drop in a young kid’s eye is tough. Putting an eye drop in your own young kid’s eye is impossible.

View more